{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:49:02Z","timestamp":1774129742047,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.clinthera.2012.06.007","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T16:22:33Z","timestamp":1341591753000},"page":"1788-1802","source":"Crossref","is-referenced-by-count":10,"title":["Cost-Effectiveness of Dronedarone in Atrial Fibrillation: Results for Canada, Italy, Sweden, and Switzerland"],"prefix":"10.1016","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct00174785","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01151137","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"\u00d6rjan","family":"\u00c5kerborg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Bascle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.06.007_bib1","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2012.06.007_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2012.06.007_bib3","series-title":"Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care","year":"2006"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2012.06.007_bib4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1540-8167.2006.00583.x","article-title":"Dronedarone: an emerging agent with rhythm- and rate-controlling effects","volume":"17","author":"Wegener","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.clinthera.2012.06.007_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2012.06.007_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/europace\/eun048","article-title":"Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation","volume":"10","author":"Ringborg","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.clinthera.2012.06.007_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/europace\/euq325","article-title":"Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries","volume":"13","author":"Holstenson","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.clinthera.2012.06.007_bib9","series-title":"Multilevel and Longitudinal Modeling Using Stata","author":"Rabe-Hesketh","year":"2005"},{"key":"10.1016\/j.clinthera.2012.06.007_bib10","series-title":"Paper presented at the Health Economists' Study Group Conference","article-title":"Parametric survival models and decision models: relating continuous hazards to discrete-time transition probabilities","author":"Briggs","year":"2004"},{"key":"10.1016\/j.clinthera.2012.06.007_bib11","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2012.06.007_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2012.06.007_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bone.2007.09.059","article-title":"Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial","volume":"42","author":"Lekander","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinthera.2012.06.007_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurheartj\/ehn541","article-title":"Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry","volume":"30","author":"Shafazand","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2012.06.007_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11136-010-9591-y","article-title":"Factors determining utility measured with the EQ-5D in patients with atrial fibrillation","volume":"19","author":"Berg","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clinthera.2012.06.007_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.STR.0000049767.14156.2C","article-title":"Cost and caregiver consequences of early supported discharge for stroke patients","volume":"34","author":"Teng","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2012.06.007_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-3999(99)00088-4","article-title":"Depression and health-care cost during the first year following a myocardial infarction","volume":"48","author":"Frasure-Smith","year":"2000","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.clinthera.2012.06.007_bib23","article-title":"National Institute for Health and Clinical Excellence","year":"2007","journal-title":"The Guidelines Manual"},{"key":"10.1016\/j.clinthera.2012.06.007_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJMoa021775","article-title":"A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients","volume":"348","author":"Nathoe","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2012.06.007_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/annonc\/mdj048","article-title":"Comparing cost\/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2\u20133 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer","volume":"17","author":"Lonning","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinthera.2012.06.007_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1745-6215-10-103","article-title":"Cost-effectiveness of postural exercise therapy versus physiotherapy in computer screen-workers with early non-specific work-related upper limb disorders (WRULD); a randomized controlled trial","volume":"10","author":"van Eijsden","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.clinthera.2012.06.007_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7326\/0003-4819-141-9-200411020-00005","article-title":"Cost-effectiveness of rhythm versus rate control in atrial fibrillation","volume":"141","author":"Marshall","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2012.06.007_bib28","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2012.06.007_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-130-8-199904200-00002","article-title":"Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation","volume":"130","author":"Catherwood","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2012.06.007_bib30","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.158.15.1669","article-title":"Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation","volume":"158","author":"Eckman","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2012.06.007_bib31","article-title":"The Cost of Hospital Stay: Why Cost Vary","year":"2008","journal-title":"Ottawa, Canada"},{"key":"10.1016\/j.clinthera.2012.06.007_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1098-3015(10)65788-9","article-title":"An economic evaluation of clopidogrel vs.aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy","volume":"7","author":"Rudelli","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2012.06.007_bib40","series-title":"Ontario Case Costing Initiative","year":"2008"},{"key":"10.1016\/j.clinthera.2012.06.007_bib41","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4414\/saez.2003.10090","article-title":"Gesundheits\u00f6konomische aspekte der chronischen herzinsuffizienz","volume":"84","author":"Szucs","year":"2003","journal-title":"Schweizeriche \u00c4rztezeitung"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812003700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812003700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T17:04:36Z","timestamp":1561914276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812003700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0149291812003700"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.06.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}